115 related articles for article (PubMed ID: 28407594)
1. Trifluoromethyl arylamides with antileukemia effect and intracellular inhibitory activity over serine/arginine-rich protein kinases (SRPKs).
Siqueira RP; Barros MVA; Barbosa ÉAA; Onofre TS; Gonçalves VHS; Pereira HS; Silva Júnior A; de Oliveira LL; Almeida MR; Fietto JLR; Teixeira RR; Bressan GC
Eur J Med Chem; 2017 Jul; 134():97-109. PubMed ID: 28407594
[TBL] [Abstract][Full Text] [Related]
2. Potential Antileukemia Effect and Structural Analyses of SRPK Inhibition by N-(2-(Piperidin-1-yl)-5-(Trifluoromethyl)Phenyl)Isonicotinamide (SRPIN340).
Siqueira RP; Barbosa Éde A; Polêto MD; Righetto GL; Seraphim TV; Salgado RL; Ferreira JG; Barros MV; de Oliveira LL; Laranjeira AB; Almeida MR; Júnior AS; Fietto JL; Kobarg J; de Oliveira EB; Teixeira RR; Borges JC; Yunes JA; Bressan GC
PLoS One; 2015; 10(8):e0134882. PubMed ID: 26244849
[TBL] [Abstract][Full Text] [Related]
3. Antimetastatic effect of the pharmacological inhibition of serine/arginine-rich protein kinases (SRPK) in murine melanoma.
Moreira GA; Lima GDA; Siqueira RP; Barros MVA; Adjanohoun ALM; Santos VC; Barbosa ÉAA; Loterio RK; Paiva JC; Gonçalves VHS; Viol LCS; Marques-da-Silva EA; Júnior AS; Almeida MR; Fietto JLR; Machado-Neves M; Ferreira RS; Teixeira RR; Bressan GC
Toxicol Appl Pharmacol; 2018 Oct; 356():214-223. PubMed ID: 30138656
[TBL] [Abstract][Full Text] [Related]
4. Immunomodulatory activity of trifluoromethyl arylamides derived from the SRPK inhibitor SRPIN340 and their potential use as vaccine adjuvant.
Mendes FC; de Paiva JC; da Silva EQG; Santos MR; de Almeida Lima GD; Moreira GA; Silva LVG; de Melo Agripino J; de Souza APM; de Oliveira Mendes TA; Machado-Neves M; Teixeira RR; Silva-Júnior A; Fietto JLR; de Oliveira LL; Bressan GC
Life Sci; 2022 Oct; 307():120849. PubMed ID: 35926588
[TBL] [Abstract][Full Text] [Related]
5. Combined SRPK and AKT pharmacological inhibition is synergistic in T-cell acute lymphoblastic leukemia cells.
Siqueira RP; Caetano MMM; de Souza LÂ; Dos Passos PMS; Simaroli NB; Barros MVA; de Souza APM; de Oliveira LL; Silva-Júnior A; Fietto JLR; Teixeira RR; Teixeira FR; Bressan GC
Toxicol In Vitro; 2020 Jun; 65():104777. PubMed ID: 31962201
[TBL] [Abstract][Full Text] [Related]
6. The SRPK inhibitor N-(2-(piperidin-1-yl)-5-(trifluoromethyl)phenyl) isonicotinamide (SRPIN340) increases the immune response against metastatic melanoma in mice.
Moreira GA; Caetano MMM; do Vale JA; de Paiva JC; Gonçalves VHS; Almeida AA; Silva LVG; Martim FRG; de Andrade Barros MV; Guimarães GR; de Oliveira Santos L; de Souza APM; Machado-Neves M; Teixeira RR; Silva-Júnior A; Fietto JLR; Boroni M; de Oliveira LL; Bressan GC
Biochem Pharmacol; 2022 Sep; 203():115161. PubMed ID: 35787994
[TBL] [Abstract][Full Text] [Related]
7. Exploration of N-(2-aminoethyl)piperidine-4-carboxamide as a potential scaffold for development of VEGFR-2, ERK-2 and Abl-1 multikinase inhibitor.
Jin F; Gao D; Wu Q; Liu F; Chen Y; Tan C; Jiang Y
Bioorg Med Chem; 2013 Sep; 21(18):5694-706. PubMed ID: 23932071
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Translocation of SRPKs Is Associated with 5-FU and Cisplatin Sensitivity in HeLa and T24 Cells.
Sigala I; Koutroumani M; Koukiali A; Giannakouros T; Nikolakaki E
Cells; 2021 Mar; 10(4):. PubMed ID: 33808326
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 5-(2-(phenylamino)pyrimidin-4-yl)thiazol-2(3H)-one derivatives as potent Mnk2 inhibitors: synthesis, SAR analysis and biological evaluation.
Diab S; Teo T; Kumarasiri M; Li P; Yu M; Lam F; Basnet SK; Sykes MJ; Albrecht H; Milne R; Wang S
ChemMedChem; 2014 May; 9(5):962-72. PubMed ID: 24677692
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents.
Jiao Y; Xin BT; Zhang Y; Wu J; Lu X; Zheng Y; Tang W; Zhou X
Eur J Med Chem; 2015 Jan; 90():170-83. PubMed ID: 25461318
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antileukemic activity of novel 2-(4-(2,4-dimethoxybenzoyl)phenoxy)-1-(4-(3-(piperidin-4-yl)propyl)piperidin-1-yl)ethanone derivatives.
Vinaya K; Kavitha CV; Prasanna DS; Chandrappa S; Ranganatha SR; Raghavan SC; Rangappa KS
Chem Biol Drug Des; 2012 Mar; 79(3):360-7. PubMed ID: 22181584
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and activities of new indolopyrrolobenzodiazepine derivatives toward acute myeloid leukemia cells.
Giraud F; Bourhis M; Ebrahimi E; Herfindal L; Choudhury RR; Bjørnstad R; Døskeland SO; Anizon F; Moreau P
Bioorg Med Chem; 2015 Nov; 23(22):7313-23. PubMed ID: 26526744
[TBL] [Abstract][Full Text] [Related]
13. Discovery of novel 2-aminopyridine-3-carboxamides as c-Met kinase inhibitors.
Zhang D; Ai J; Liang Z; Li C; Peng X; Ji Y; Jiang H; Geng M; Luo C; Liu H
Bioorg Med Chem; 2012 Sep; 20(17):5169-80. PubMed ID: 22863529
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives.
El-Gamal MI; Abdel-Maksoud MS; Gamal El-Din MM; Shin JS; Lee KT; Yoo KH; Oh CH
Anticancer Agents Med Chem; 2017; 17(1):75-84. PubMed ID: 27334850
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf.
Chen KF; Tai WT; Huang JW; Hsu CY; Chen WL; Cheng AL; Chen PJ; Shiau CW
Eur J Med Chem; 2011 Jul; 46(7):2845-51. PubMed ID: 21531053
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antileukemic activity of novel 4-(3-(piperidin-4-yl) propyl)piperidine derivatives.
Vinaya K; Kavitha CV; Chandrappa S; Prasanna DS; Raghavan SC; Rangappa KS
Chem Biol Drug Des; 2011 Oct; 78(4):622-30. PubMed ID: 21756286
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, broad-spectrum antiproliferative activity, and kinase inhibitory effect of triarylpyrazole derivatives possessing arylamides or arylureas moieties.
Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH
Eur J Med Chem; 2016 Aug; 119():122-31. PubMed ID: 27155467
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing.
Araki S; Dairiki R; Nakayama Y; Murai A; Miyashita R; Iwatani M; Nomura T; Nakanishi O
PLoS One; 2015; 10(1):e0116929. PubMed ID: 25581376
[TBL] [Abstract][Full Text] [Related]
19. 7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: a novel class of Pim kinase inhibitors with potent cell antiproliferative activity.
Pierre F; Stefan E; Nédellec AS; Chevrel MC; Regan CF; Siddiqui-Jain A; Macalino D; Streiner N; Drygin D; Haddach M; O'Brien SE; Anderes K; Ryckman DM
Bioorg Med Chem Lett; 2011 Nov; 21(22):6687-92. PubMed ID: 21982499
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of c-Src kinase inhibitory activity of pyridin-2(1H)-one derivatives.
Chand K; Prasad S; Tiwari RK; Shirazi AN; Kumar S; Parang K; Sharma SK
Bioorg Chem; 2014 Apr; 53():75-82. PubMed ID: 24632506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
